http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107177010-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fced52a9fc48a318be09e2f29a2a531b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0075 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10 |
| filingDate | 2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7cf9ca430331d3ebd7e9d8b7ef54fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d95f88596d2813df67c600cfdf2cf5df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77c4e8c61c525cbe49affbf915fa072d |
| publicationDate | 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107177010-A |
| titleOfInvention | The screening technology of liquaemin special enzyme preparation |
| abstract | The invention discloses a kind of screening technology of liquaemin special enzyme preparation, make refined heparin sodium molecular weight between 15000-19000 dalton, and the ratio of molecular weight ratio is not less than 1.0 between the molecular weight ratio and 16000-24000 dalton of 8000-16000 dalton.Technical scheme is that the consumption for using regulation trypsase and pepsin in enzymolysis process decomposes the macromolecule liquaemin in liquaemin, the purification step repeatedly precipitated by ethanol again, aoxidized realizes that the impurity such as liquaemin and other ribonucleic acid is completely separated, refined heparin sodium yield reaches that other quality standards meet Chinese Pharmacopoeia, American Pharmacopeia, British Pharmacopoeia and West Europe States Pharmacopoeia specifications to more than 90%, Xa potency for 0.9-1.1 with IIa potency ratio. |
| priorityDate | 2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.